hydroxyethylrutoside
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Dec 8, 2020 (NCT04670432)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05681312 | Phase 3 | Oct 1, 2023 | University of Baghdad |
| NCT04670432 | Phase 3 | Dec 8, 2020 | Maastricht University, Netherlands Thrombosis Foundation |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Maastricht University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Netherlands Thrombosis Foundation | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Baghdad | Academic/Hospital | 1 | 1 | 1 | 2023 |
3 organizations
Page 1 / 1